Hawaii Officials Defend Hemp Crackdown in Court Filing

State Cites Testing Gap as Legal Justification

Hawaii's defense centers on a testing disparity: hemp products sold at retail avoid the laboratory screening mandated for medical marijuana. According to court filings, state officials argue that hemp-derived edibles and pre-rolls enter commerce without potency verification, pesticide panels, or microbial testing—standards the Department of Health enforces for licensed dispensaries.

The motion responds to a complaint brought by hemp retailers and manufacturers after the state issued emergency rules in July 2026 effectively banning the sale of intoxicating hemp products statewide. The emergency order classified products containing delta-8 THC, delta-10 THC, and other semi-synthetic cannabinoids as controlled substances. It shuttered a retail channel that had operated in a regulatory gray zone since the 2018 Farm Bill federally legalized hemp.

"There are products that have not been subject to the same rigorous testing that the medical marijuana requires," a state official said in a statement accompanying the filing.

Retail Impact: Empty Shelves, Lost Revenue

Hemp retailers report immediate revenue loss following the July order. Blake Birdwell, a customer at Oʻahu Dispensary and Provisions in Waikīkī, represents a common scenario: walk-in traffic seeking pre-rolls or edibles now leaves empty-handed. Store managers confirm the products were pulled from inventory within days of the emergency rule taking effect.

A coalition of hemp businesses filed the lawsuit. They argue the crackdown violates due process and exceeds the Department of Health's statutory authority. Plaintiffs contend the state failed to provide notice-and-comment rulemaking and that the emergency classification lacks a factual basis. For full background on this story, see the CannIntel topic hub on Hawaii's hemp crackdown.

Legal Timeline and Next Steps

The motion to dismiss was filed August 15, 2026, in Hawaii state court. No hearing date yet. If the court denies the motion, discovery would proceed into fall 2026, with depositions likely targeting Department of Health rulemaking records and internal risk assessments.

Industry attorneys have signaled they'll seek a preliminary injunction to restore sales pending trial. The state hasn't indicated whether it will oppose expedited briefing.

Broader Policy Context

Hawaii joins at least 14 states that have restricted or banned intoxicating hemp products since 2024. The enforcement wave follows a 2023 USDA clarification that the Farm Bill's THC limit applies to delta-9 THC only, leaving semi-synthetic analogs in a federal compliance gap. States including Oregon, Colorado, and Minnesota have enacted testing and labeling rules; Hawaii opted for an outright prohibition.

The state's testing argument mirrors the rationale used in Oregon's 2025 hemp rules, which imposed lab-testing requirements identical to those for adult-use cannabis.

Hawaii doesn't permit adult-use cannabis sales. The state's medical marijuana program, launched in 2017, serves approximately 35,000 registered patients through eight licensed dispensaries.